As an inflammatory factor, IL-33 can promote the pathological development of diseases like asthma, allergic rhinitis and rheumatoid arthritis by inducing type2-immune response and activating mast cells (10–13). The gene discussed is IL33; the disease is rheumatoid arthritis.